Advertisement

Topics

WBA’s full-year results bring double-digit earnings growth

08:46 EDT 11 Oct 2018 | Drug Store News

The company reported a sales increase of 11.3% for fiscal year 2018, bringing its revenue to $131.5 billion, with adjusted earnings per share growing 18% to $6.02. generic via filter on get_the_excerpt -->

generic via filter on get_the_excerpt -->

Read More

Original Article: WBA’s full-year results bring double-digit earnings growth

NEXT ARTICLE

More From BioPortfolio on "WBA’s full-year results bring double-digit earnings growth"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...